A Converse 4-1BB and CD40 Ligand Expression Pattern Delineates Activated Regulatory T Cells (Treg) and Conventional T Cells Enabling Direct Isolation of Alloantigen-Reactive Natural Foxp3+ Treg
暂无分享,去创建一个
C. Loddenkemper | A. Thiel | Jun Dong | C. Romagnani | J. Sieper | S. Kohler | H. Dooms | M. Frentsch | A. Schoenbrunn | J. Keye | Beate Moewes | Nadine Matzmohr | P. Wu
[1] G. Hansen,et al. CD137 deficiency does not affect development of airway inflammation or respiratory tolerance induction in murine models , 2012, Clinical and experimental immunology.
[2] M. Betjes,et al. Identification of Circulating Human Antigen-Reactive CD4+FOXP3+ Natural Regulatory T Cells , 2012, The Journal of Immunology.
[3] J. Pidala,et al. Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly. , 2011, Blood.
[4] J. Snick,et al. Signals through 4-1BB inhibit T regulatory cells by blocking IL-9 production enhancing antitumor responses , 2011, Cancer Immunology, Immunotherapy.
[5] T. Chatila,et al. A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity. , 2011, Immunity.
[6] R. Lechler,et al. Human Regulatory T Cells with Alloantigen Specificity Are More Potent Inhibitors of Alloimmune Skin Graft Damage than Polyclonal Regulatory T Cells , 2011, Science Translational Medicine.
[7] B. Falini,et al. Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. , 2011, Blood.
[8] B. Dörken,et al. Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study , 2011, Gene Therapy.
[9] B. Baban,et al. Reprogrammed foxp3(+) regulatory T cells provide essential help to support cross-presentation and CD8(+) T cell priming in naive mice. , 2010, Immunity.
[10] Y. Belkaid,et al. Expression of Helios, an Ikaros Transcription Factor Family Member, Differentiates Thymic-Derived from Peripherally Induced Foxp3+ T Regulatory Cells , 2010, The Journal of Immunology.
[11] C. Benoist,et al. Genomic definition of multiple ex vivo regulatory T cell subphenotypes , 2010, Proceedings of the National Academy of Sciences.
[12] A. Ganser,et al. Alloantigen‐specific de novo‐induced Foxp3+ Treg revert in vivo and do not protect from experimental GVHD , 2009, European journal of immunology.
[13] A. Rudensky,et al. Control of regulatory T cell lineage commitment and maintenance. , 2009, Immunity.
[14] G. Illei,et al. Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I/II (CD121a/CD121b) on activated human FOXP3+ regulatory T cells allows for their purification from expansion cultures. , 2009, Blood.
[15] M. Rossol,et al. Cytokine-induced human IFN-gamma-secreting effector-memory Th cells in chronic autoimmune inflammation. , 2009, Blood.
[16] D. Niedzwiecki,et al. Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines. , 2008, Blood.
[17] X. Wang,et al. Agonistic Anti‐4‐1BB Antibody Promotes the Expansion of Natural Regulatory T Cells While Maintaining Foxp3 Expression , 2007, Scandinavian journal of immunology.
[18] M. Battaglia,et al. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans , 2007, Nature Reviews Immunology.
[19] P. Greenberg,et al. Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities. , 2007, Blood.
[20] R. Selvaraj,et al. A Kinetic and Dynamic Analysis of Foxp3 Induced in T Cells by TGF-β1 , 2007, The Journal of Immunology.
[21] Kutlu G. Elpek,et al. CD4+CD25+ T Regulatory Cells Dominate Multiple Immune Evasion Mechanisms in Early but Not Late Phases of Tumor Development in a B Cell Lymphoma Model1 , 2007, The Journal of Immunology.
[22] Ernest Fraenkel,et al. Foxp3 occupancy and regulation of key target genes during T-cell stimulation , 2007, Nature.
[23] Edgar Schmitt,et al. Epigenetic Control of the foxp3 Locus in Regulatory T Cells , 2007, PLoS biology.
[24] W. Zou. Regulatory T cells, tumour immunity and immunotherapy , 2006, Nature Reviews Immunology.
[25] E. Holler,et al. Isolation of CD4+CD25+ regulatory T cells for clinical trials. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[26] Andreas Thiel,et al. Direct access to CD4+ T cells specific for defined antigens according to CD154 expression , 2005, Nature Medicine.
[27] Mario Roederer,et al. A live-cell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles , 2005, Nature Medicine.
[28] H. Mcdevitt,et al. Expansion of Functional Endogenous Antigen-Specific CD4+CD25+ Regulatory T Cells from Nonobese Diabetic Mice1 , 2005, The Journal of Immunology.
[29] A. Vella,et al. Interfacing T-cell effector and regulatory function through CD137 (4-1BB) co-stimulation. , 2005, Trends in immunology.
[30] B. Kwon,et al. Enhanced CD4 T Cell Responsiveness in the Absence of 4-1BB1 , 2005, The Journal of Immunology.
[31] Aoshuang Chen,et al. The 4-1BB Costimulation Augments the Proliferation of CD4+CD25+ Regulatory T Cells1 , 2004, The Journal of Immunology.
[32] Y. Belkaid,et al. Role for CD4+ CD25+ Regulatory T Cells in Reactivation of Persistent Leishmaniasis and Control of Concomitant Immunity , 2004, The Journal of experimental medicine.
[33] Jeffrey A. Bluestone,et al. In Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune Diabetes , 2004, The Journal of experimental medicine.
[34] J. Bae,et al. 4‐1BB‐dependent inhibition of immunosuppression by activated CD4+CD25+ T cells , 2004, Journal of leukocyte biology.
[35] D. Klatzmann,et al. Continuous Activation of Autoreactive CD4+ CD25+ Regulatory T Cells in the Steady State , 2003, The Journal of experimental medicine.
[36] Anna Chodos,et al. Antigen-dependent Proliferation of CD4+ CD25+ Regulatory T Cells In Vivo , 2003, The Journal of experimental medicine.
[37] Li-Sheng Lu,et al. A T Cell-specific Enhancer of the Human CD40 Ligand Gene* , 2002, The Journal of Biological Chemistry.
[38] M. Byrne,et al. CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. , 2002, Immunity.
[39] Sayuri Yamazaki,et al. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance , 2001, Immunological reviews.
[40] O. Joffre,et al. Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes , 2008, Nature Medicine.
[41] Ramesh K Selvaraj,et al. A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-beta. , 2007, Journal of Immunology.
[42] T. Watts,et al. TNF/TNFR family members in costimulation of T cell responses. , 2005, Annual review of immunology.